Trefoil factor 2 negatively regulates type 1 immunity against Toxoplasma gondii

Journal of Immunology

Volumn 189, Issue 6, 2012, Pages 3078-3084

  McBerry, Cortez ^a   Egan, Charlotte E ^b   Rani, Reena ^a   Yang, Yanfen ^a   Wu, David ^a   Boespflug, Nicholas ^a   Boon, Louis ^c   Butcher, Barbara ^b   Mirpuri, Julie ^d   Hogan, Simon P ^a   Denkers, Eric Y ^b   Aliberti, Julio ^a   Herbert, De'Broski R ^a  

^a CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

^b Animal Health Diagnostic Center   (United States)

^c BIOCEROS   (Netherlands)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 12P40; INTERLEUKIN 12P70; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; TOLL LIKE RECEPTOR; TREFOIL FACTOR 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ DENDRITIC CELL; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; EFFECTOR CELL; ENZYME ACTIVATION; ILEITIS; IMMUNITY; IMMUNOPATHOGENESIS; IMMUNOREGULATION; INTERFERON PRODUCTION; INTESTINE; MACROPHAGE; MOUSE; NONHUMAN; PARASITE CLEARANCE; PHAGOCYTE; PRIORITY JOURNAL; TH1 CELL; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; DOWN-REGULATION; IMMUNITY, CELLULAR; INFLAMMATION; INTESTINAL MUCOSA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUCINS; MUSCLE PROTEINS; PEPTIDES; PHAGOCYTOSIS; TOXOPLASMA; TOXOPLASMOSIS;

EID: 84866145916     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1103374     Document Type: Article

References (43)

1. Munoz, M., O. Liesenfeld, and M. M. Heimesaat. 2011. Immunology of Toxoplasma gondii. Immunol. Rev. 240: 269-285.
2. Lieberman, L. A., and C. A. Hunter. 2002. The role of cytokines and their signaling pathways in the regulation of immunity to Toxoplasma gondii. Int. Rev. Immunol. 21: 373-403.
3. + effector subpopulations during Toxoplasma gondii Infection. J. Immunol. 180: 5935-5945.
4. Sher, A., E. Y. Denkers, and R. T. Gazzinelli. 1995. Induction and regulation of host cell-mediated immunity by Toxoplasma gondii. Ciba Found. Symp. 195: 95-104, discussion 104-109.
5. Gazzinelli, R. T., M. Wysocka, S. Hayashi, E. Y. Denkers, S. Hieny, P. Caspar, G. Trinchieri, and A. Sher. 1994. Parasite-induced IL-12 stimulates early IFN-γ synthesis and resistance during acute infection with Toxoplasma gondii. J. Immunol. 153: 2533-2543. (Pubitemid 24278122)
6. Villegas, E. N., L. A. Lieberman, S. R. Carding, and C. A. Hunter. 2002. Susceptibility of interleukin-2-deficient mice to Toxoplasma gondii is associated with a defect in the production of gamma interferon. Infect. Immun. 70: 4757-4761.
7. Gaddi, P. J., and G. S. Yap. 2007. Cytokine regulation of immunopathology in toxoplasmosis. Immunol. Cell Biol. 85: 155-159. (Pubitemid 46398730)
8. Benson, A., R. Pifer, C. L. Behrendt, L. V. Hooper, and F. Yarovinsky. 2009. Gut commensal bacteria direct a protective immune response against Toxoplasma gondii. Cell Host Microbe 6: 187-196.
9. Hoffmann, W. 2005. Trefoil factors TFF (trefoil factor family) peptide-triggered signals promoting mucosal restitution. Cell. Mol. Life Sci. 62: 2932-2938. (Pubitemid 43004746)
10. Göke, M. N., J. R. Cook, K. S. Kunert, M. E. Fini, I. K. Gipson, and D. K. Podolsky. 2001. Trefoil peptides promote restitution of wounded corneal epithelial cells. Exp. Cell Res. 264: 337-344.
11. Kurt-Jones, E. A., L. Cao, F. Sandor, A. B. Rogers, M. T. Whary, P. R. Nambiar, A. Cerny, G. Bowen, J. Yan, S. Takaishi, et al. 2007. Trefoil family factor 2 is expressed in murine gastric and immune cells and controls both gastrointestinal inflammation and systemic immune responses. Infect. Immun. 75: 471-480. (Pubitemid 46047923)
12. Poulsen, S. S., H. Kissow, K. Hare, B. Hartmann, and L. Thim. 2005. Luminal and parenteral TFF2 and TFF3 dimer and monomer in two models of experimental colitis in the rat. Regul. Pept. 126: 163-171. (Pubitemid 40128181)
13. Baus-Loncar, M., J. Schmid, N. Lalani, I. Rosewell, R. A. Goodlad, G. W. Stamp, N. Blin, and T. Kayademir. 2005. Trefoil factor 2 (TFF2) deficiency in murine digestive tract influences the immune system. Cell. Physiol. Biochem. 16: 31-42. (Pubitemid 41197086)
14. Sukhumavasi, W., C. E. Egan, A. L. Warren, G. A. Taylor, B. A. Fox, D. J. Bzik, and E. Y. Denkers. 2008. TLR adaptor MyD88 is essential for pathogen control during oral Toxoplasma gondii infection but not adaptive immunity induced by a vaccine strain of the parasite. J. Immunol. 181: 3464-3473.
15. Butcher, B. A., B. A. Fox, L. M. Rommereim, S. G. Kim, K. J. Maurer, F. Yarovinsky, D. R. Herbert, D. J. Bzik, and E. Y. Denkers. 2011. Toxoplasma gondii rhoptry kinase ROP16 activates STAT3 and STAT6 resulting in cytokine inhibition and arginase-1-dependent growth control. PLoS Pathog. 7: e1002236.
16. Rani, R., A. G. Smulian, D. R. Greaves, S. P. Hogan, and D. R. Herbert. 2011. TGF-β limits IL-33 production and promotes the resolution of colitis through regulation of macrophage function. Eur. J. Immunol. 41: 2000-2009.
17. Herbert, D. R., J. Q. Yang, S. P. Hogan, K. Groschwitz, M. Khodoun, A. Munitz, T. Orekov, C. Perkins, Q. Wang, F. Brombacher, et al. 2009. Intestinal epithelial cell secretion of RELM-β protects against gastrointestinal worm infection. J. Exp. Med. 206: 2947-2957.
18. Kim, L., L. Del Rio, B. A. Butcher, T. H. Mogensen, S. R. Paludan, R. A. Flavell, and E. Y. Denkers. 2005. p38 MAPK autophosphorylation drives macrophage IL-12 production during intracellular infection. J. Immunol. 174: 4178-4184. (Pubitemid 40395996)
19. + dendritic cells. Nat. Immunol. 1: 83-87.
20. Yarovinsky, F., D. Zhang, J. F. Andersen, G. L. Bannenberg, C. N. Serhan, M. S. Hayden, S. Hieny, F. S. Sutterwala, R. A. Flavell, S. Ghosh, and A. Sher. 2005. TLR11 activation of dendritic cells by a protozoan profilin-like protein. Science 308: 1626-1629. (Pubitemid 40807512)
21. Trinchieri, G., S. Pflanz, and R. A. Kastelein. 2003. The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity 19: 641-644. (Pubitemid 37490789)
22. Hunter, C. A., E. Candolfi, C. Subauste, V. Van Cleave, and J. S. Remington. 1995. Studies on the role of interleukin-12 in acute murine toxoplasmosis. Immunology 84: 16-20.
23. Trinchieri, G. 2003. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3: 133-146. (Pubitemid 37328691)
24. Sher, A., C. Collazzo, C. Scanga, D. Jankovic, G. Yap, and J. Aliberti. 2003. Induction and regulation of IL-12-dependent host resistance to Toxoplasma gondii. Immunol. Res. 27: 521-528.
25. Suzuki, Y., A. Sher, G. Yap, D. Park, L. E. Neyer, O. Liesenfeld, M. Fort, H. Kang, and E. Gufwoli. 2000. IL-10 is required for prevention of necrosis in the small intestine and mortality in both genetically resistant BALB/c and susceptible C57BL/6 mice following peroral infection with Toxoplasma gondii. J. Immunol. 164: 5375-5382. (Pubitemid 30305218)
26. Muñoz, M., M. M. Heimesaat, K. Danker, D. Struck, U. Lohmann, R. Plickert, S. Bereswill, A. Fischer, I. R. Dunay, K. Wolk, et al. 2009. Interleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17. J. Exp. Med. 206: 3047-3059.
27. Strober, W., I. J. Fuss, and R. S. Blumberg. 2002. The immunology of mucosal models of inflammation. Annu. Rev. Immunol. 20: 495-549. (Pubitemid 34293433)
28. Liesenfeld, O. 2002. Oral infection of C57BL/6 mice with Toxoplasma gondii: a new model of inflammatory bowel disease? J. Infect. Dis. 185(Suppl. 1): S96-S101. (Pubitemid 34142835)
29. Hogan, S. P., L. Seidu, C. Blanchard, K. Groschwitz, A. Mishra, M. L. Karow, R. Ahrens, D. Artis, A. J. Murphy, D. M. Valenzuela, et al. 2006. Resistin-like molecule β regulates innate colonic function: barrier integrity and inflammation susceptibility. J. Allergy Clin. Immunol. 118: 257-268. (Pubitemid 43946483)
30. - secretion. J. Biol. Chem. 286: 13357-13369.
31. Heller, F., P. Florian, C. Bojarski, J. Richter, M. Christ, B. Hillenbrand, J. Mankertz, A. H. Gitter, N. Bürgel, M. Fromm, et al. 2005. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology 129: 550-564. (Pubitemid 41096643)
32. Playford, R. J., T. Marchbank, R. A. Goodlad, R. A. Chinery, R. Poulsom, and A. M. Hanby. 1996. Transgenic mice that overexpress the human trefoil peptide pS2 have an increased resistance to intestinal damage. Proc. Natl. Acad. Sci. USA 93: 2137-2142. (Pubitemid 26079894)
33. Mashimo, H., D. C. Wu, D. K. Podolsky, and M. C. Fishman. 1996. Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science 274: 262-265. (Pubitemid 26353206)
34. Soriano-Izquierdo, A., M. Gironella, A. Massaguer, F. E. May, A. Salas, M. Sans, R. Poulsom, L. Thim, J. M. Piqué, and J. Panés. 2004. Trefoil peptide TFF2 treatment reduces VCAM-1 expression and leukocyte recruitment in experimental intestinal inflammation. J. Leukoc. Biol. 75: 214-223. (Pubitemid 38174577)
35. Siu, L. S., H. Romanska, P. D. Abel, M. Baus-Loncar, T. Kayademir, G. W. Stamp, and N. Lalani. 2004. TFF2 (trefoil family factor2) inhibits apoptosis in breast and colorectal cancer cell lines. Peptides 25: 855-863. (Pubitemid 38721353)
36. Kinoshita, K., D. R. Taupin, H. Itoh, and D. K. Podolsky. 2000. Distinct pathways of cell migration and antiapoptotic response to epithelial injury: structurefunction analysis of human intestinal trefoil factor. Mol. Cell. Biol. 20: 4680-4690. (Pubitemid 30396115)
37. May, F. E., J. I. Semple, S. J. Prest, and B. R. Westley. 2004. Expression and motogenic activity of TFF2 in human breast cancer cells. Peptides 25: 865-872. (Pubitemid 38721354)
38. Labouvie, C., J. C. Machado, F. Carneiro, M. Sarbia, M. Vieth, R. Porschen, G. Seitz, and N. Blin. 1999. Differential expression of mucins and trefoil peptides in native epithelium, Barrett's metaplasia and squamous cell carcinoma of the oesophagus. J. Cancer Res. Clin. Oncol. 125: 71-76. (Pubitemid 29161457)
39. Tu, S. P., A. L. Chi, W. Ai, S. Takaishi, Z. Dubeykovskaya, M. Quante, J. G. Fox, and T. C. Wang. 2009. p53 inhibition of AP1-dependent TFF2 expression induces apoptosis and inhibits cell migration in gastric cancer cells. Am. J. Physiol. Gastrointest. Liver Physiol. 297: G385-G396.
40. Dhar, D. K., T. C. Wang, R. Maruyama, J. Udagawa, H. Kubota, T. Fuji, M. Tachibana, T. Ono, H. Otani, and N. Nagasue. 2003. Expression of cytoplasmic TFF2 is a marker of tumor metastasis and negative prognostic factor in gastric cancer. Lab. Invest. 83: 1343-1352. (Pubitemid 37140319)
41. Sun, Y., W. Wu, Y. Zhang, S. Lv, L. Wang, S. Wang, and X. Peng. 2009. Stability analysis of recombinant human TFF2 and its therapeutic effect on burn-induced gastric injury in mice. Burns 35: 869-874.
42. Poulsen, S. S., J. Thulesen, L. Christensen, E. Nexo, and L. Thim. 1999. Metabolism of oral trefoil factor 2 (TFF2) and the effect of oral and parenteral TFF2 on gastric and duodenal ulcer healing in the rat. Gut 45: 516-522. (Pubitemid 29447818)
43. Guiton, R., V. Vasseur, S. Charron, M. T. Arias, N. Van Langendonck, D. Buzoni-Gatel, B. Ryffel, and I. Dimier-Poisson. 2010. Interleukin 17 receptor signaling is deleterious during Toxoplasma gondii infection in susceptible BL6 mice. J. Infect. Dis. 202: 427-435.